Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Nociception01:44

Nociception

29.4K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IFNα and bleomycin-induced DNA damage activate distinct stress responses in human islets and induced pluripotent stem cell-derived islet cells.

Islets·2026
Same author

Dirhamnolipids from <i>Pseudomonas aeruginosa</i> PAO1 Protect Hairless Mouse Skin from UVB-Induced Inflammation and Oxidative Stress.

ACS omega·2026
Same author

Flavonoids as Nutraceuticals to Treat Inflammatory Diseases: Focusing on Quercetin, Kaempferol, Luteolin, Apigenin, Epicatechin and Their Effects on Hepatic, Nervous, and Pulmonary Systems.

Foods (Basel, Switzerland)·2026
Same author

Influence of Chondroitin Sulfate Concentration on the Physicochemical Properties of Acetaminophen-Releasing Cellulose/PVOH Membranes.

ACS omega·2026
Same author

<i>Trans</i>-Chalcone Reduces Inflammation and Pain Triggered by Superoxide Anion: Neuronal and Non-Neuronal Mechanisms.

Journal of inflammation research·2026
Same author

Glyphosate Bioremediation Facilitated by <i>Serratia ureilytica</i>-Derived Biosurfactants Using Amazonian Biodiversity: Genomic Insights and Adsorption Dynamics.

Journal of xenobiotics·2026

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects &#8212; Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

1.7K

Targeted-Produced Dirhamnolipids from Pseudomonas aeruginosa Induce Antinociception in Mice.

Kamila B B Wessel1, Ana Paula Mello2, Ismael Rodrigues Amador1

  • 1Departamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.

ACS Omega
|August 25, 2025
PubMed
Summary

Dirhamnolipids, potent biosurfactants, demonstrate significant antinociceptive effects on inflammatory pain in mice. This study details their purification and mechanism, revealing potential for novel pain therapeutics.

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.5K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.6K

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects &#8212; Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

1.7K
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.5K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.6K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Biotechnology

Background:

  • Rhamnolipids are effective biosurfactants with biomedical potential.
  • Dirhamnolipids, a specific type, show promise but their pain-relieving effects were unexplored.
  • Existing research focused on antimicrobial and wound healing properties.

Purpose of the Study:

  • To develop a targeted production and purification process for highly pure dirhamnolipids.
  • To investigate the antinociceptive and anti-inflammatory effects of purified dirhamnolipids (pDi-RL).
  • To elucidate the underlying mechanisms of dirhamnolipid's pain-relieving activity.

Main Methods:

  • Developed a targeted process yielding 95.1% dirhamnolipid abundance.
  • Purified dirhamnolipids using a single-step silica cartridge method.
  • Evaluated pDi-RL efficacy in murine models of carrageenan, acetic acid, and formalin-induced pain and inflammation.

Main Results:

  • A highly pure dirhamnolipid preparation (97.5% purity) was obtained.
  • The 3 mg/kg dose of pDi-RL significantly reduced pain sensitivity, leukocyte infiltration, and inflammatory behaviors.
  • pDi-RL inhibited leukocyte recruitment and superoxide anion production in a peritonitis model.

Conclusions:

  • This study demonstrates for the first time the antinociceptive activity of dirhamnolipids.
  • Purified dirhamnolipids show therapeutic potential for managing inflammatory pain.
  • The findings provide insights into the mechanisms of dirhamnolipid-mediated pain relief.